You searched for "prevention"

2949 results found

EUHA 2025: 69th International Congress of Hearing Aid Acousticians

EUHA 2025: 69th International Congress of Hearing Aid Acousticians will be held in Nuremberg, Germany, from 22 to 24 October 2025 We are building on last year's success and presenting our EUHA Live Area as a central meeting and networking area with special programme. It will be located in the Industry Exhibition. The event consists of a specialist conference featuring international lecturers and a trade fair with exhibitors from Germany and abroad. The EUHA Live Area connects the Congress and the Industry Exhibition even more closely. A central meeting and networking area with a stage will be created in the exhibition hall, where visitors can get information on the different topics.

Telepractice for the delivery of paediatric feeding services

During the current COVID-19 pandemic, telepractice is being heralded as the safest service delivery mode for the majority of outpatient consultations. Patients are reviewed by their healthcare specialist through video consultations, thus avoiding the need for patients to leave their...

Improving music perception in cochlear implant users

Can you imagine a world without music? In the words of Hans Christian Anderson, a prolific 19th-century Danish author, “Where words fail, music speaks.” This quote highlights music’s importance as a language of emotions that transcends linguistic barriers. This case...

Making healthcare conferences green

Who knew our healthcare conference industry contributed so much to global carbon emissions? This article summarises means to reduce the impact such that we can continue to meet with our peers for educational meetings and networking, but in a sustainable...

Semicircular canal dehiscence and cochlear implantation

Semicircular canal dehiscence (SCD) is thought to occur in 3% of the population, it is mostly asymptomatic, but patients may present with sound-induced vestibular symptoms, low-frequency conductive hearing loss, autophony, hyperacusis and aural fulness. With the increasing utilisation of cochlear...

Rapid genetic testing to avoid hearing loss in neonates

Thousands of newborn babies could avoid a lifetime of hearing loss thanks to a new rapid genetic test. In this article, we learn how. We have demonstrated for the first time that a rapid genetic test from a cheek swab...

Spring RAMI Section of Oto-Rhinolaryngology Head and Neck Surgery Prize Meeting

The Spring RAMI Section of Oto-Rhinolaryngology Head and Neck Surgery Prize Meeting, held on 28 March 2025 in Portlaoise, proved to be an exceptional gathering of both current and future leaders in the field.

N-acetylcysteine may have a role in the protection of cochlear hair cells

Gentamycin is an aminoglycoside antibiotic which is widely used throughout the world, despite its ototoxic potential. It therefore seems wise to continue the search for accessible otoprotective agents. The aim of this study was to clarify the potential protective role...

General overview of endoscopic ear surgery: advantages and principles

The philosophy of endoscopic ear surgery presents surgeons with a tricky concept – does the magnificent view make up for the fact I need to operate with one hand? In this article, Jane Lea discusses the advantages of operating transcanal...

Chronic rhinitis endotypes

Chronic rhinitis (CR) is common with up to 30% of the population affected, with a significant impact on quality of life. CR includes several phenotypes with different pathogenesis including allergy, autoimmune, age, occupation, pregnancy, neurogenic and drugs. Such variation means...

Reactive lesions of the contralateral vocal cord – excise or leave?

It is well recognised that benign lesions of one vocal cord can give rise to reactive lesions of the contralateral vocal cord directly opposite to the primary lesion. These contralateral reactive lesions (CRLs) are thought to arise due to impact...

Bones, stones and surgical moans: rethinking PTH dynamics in parathyroid surgery

Intraoperative parathyroid hormone (IOPTH) testing has revolutionised minimally invasive unilateral parathyroidectomy (MIP) as the gold standard treatment for primary hyperparathyroidism, replacing old-timey four-gland exploration. IOPTH testing ensures reliable excision of all hypersecreting glands, including those pesky hard-to-find ones, without relying...